AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2019
Apr 15, 2019
35066_dirs_2019-04-15_b3bfc24e-bd0c-4091-8fb4-ac1543ac0d17.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2019-04-04
Reporting Person: Japour Anthony J (Director)
More from Cocrystal Pharma, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15
Director's Dealing
2026
Jan 13